Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Immuuntherapie ook in de echte wereld succesvol bij gevorderd merkelcelcarcinoom
dec 2020 | Dermato-oncologie, Immuuntherapie